United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone
13. Januar 2023 15:00 ET
|
Nurexone Biologic Inc
HAIFA, Israel and CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CVE) (J90:FRA) (the “Company” or “NurExone”), a biopharmaceutical company developing...